PDB Short entry for 5FRI HEADER TRANSFERASE 17-DEC-15 5FRI TITLE ALK5 IN COMPLEX WITHA AN N-(4-ANILINO-2-PYRIDYL)ACETAMIDE INHIBITOR. COMPND MOL_ID: 1; COMPND 2 MOLECULE: TGF-BETA RECEPTOR TYPE-1; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 200-498; COMPND 5 SYNONYM: TGFR-1, ALK5, ACTIVIN A RECEPTOR TYPE II-LIKE PROTEIN KINASE COMPND 6 OF 53KD, ACTIVIN RECEPTOR-LIKE KINASE 5, ALK-5, ALK5, COMPND 7 SERINE/THREONINE-PROTEIN KINASE RECEPTOR R4, SKR4, TGF-BETA TYPE I COMPND 8 RECEPTOR, TRANSFORMING GROWTH FACTOR-BETA RECEPTOR TYPE I, TGF-BETA COMPND 9 RECEPTOR TYPE I, TBETAR-I; COMPND 10 EC: 2.7.11.30; COMPND 11 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR F.W.GOLDBERG,P.DAUNT,S.E.PEARSON,R.GREENWOOD,J.DEBRECZENI,M.GRIST REVDAT 3 08-MAY-19 5FRI 1 REMARK REVDAT 2 16-MAY-18 5FRI 1 JRNL REMARK REVDAT 1 27-JUL-16 5FRI 0 JRNL AUTH F.W.GOLDBERG,P.DAUNT,S.E.PEARSON,R.GREENWOOD,J.DEBRECZENI, JRNL AUTH 2 M.GRIST JRNL TITL IDENTIFICATION AND OPTIMISATION OF A SERIES OF JRNL TITL 2 N-(4-ANILINO-2-PYRIDYL)ACETAMIDE ACTIVIN RECEPTOR-LIKE JRNL TITL 3 KINASE 1 (ALK1) INHIBITORS JRNL REF MED. CHEM. COMMUN. V. 7 1204 2016 JRNL REFN JRNL DOI 10.1039/C6MD00039H REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0102 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 19007 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.164 REMARK 3 R VALUE (WORKING SET) : 0.162 REMARK 3 FREE R VALUE : 0.193 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.200 REMARK 3 FREE R VALUE TEST SET COUNT : 1034 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.00 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.05 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1346 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.30 REMARK 3 BIN R VALUE (WORKING SET) : 0.1790 REMARK 3 BIN FREE R VALUE SET COUNT : 73 REMARK 3 BIN FREE R VALUE : 0.2000 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2396 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 31 REMARK 3 SOLVENT ATOMS : 241 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 19.13 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.48000 REMARK 3 B22 (A**2) : 1.29000 REMARK 3 B33 (A**2) : -0.81000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.180 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.140 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.090 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 6.740 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.955 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.939 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2497 ; 0.009 ; 0.020 REMARK 3 BOND LENGTHS OTHERS (A): 1734 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3374 ; 1.179 ; 1.940 REMARK 3 BOND ANGLES OTHERS (DEGREES): 4185 ; 0.820 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 304 ; 5.832 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 116 ;33.280 ;22.750 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 439 ;12.771 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 24 ;18.825 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 363 ; 0.074 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2805 ; 0.004 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 538 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1497 ; 0.902 ; 2.000 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 616 ; 0.168 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2409 ; 1.560 ; 3.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1000 ; 0.993 ; 2.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 960 ; 1.610 ; 3.000 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 198 A 284 REMARK 3 ORIGIN FOR THE GROUP (A): 8.6131 15.6972 2.8587 REMARK 3 T TENSOR REMARK 3 T11: 0.0088 T22: 0.0570 REMARK 3 T33: 0.0256 T12: -0.0044 REMARK 3 T13: 0.0114 T23: 0.0138 REMARK 3 L TENSOR REMARK 3 L11: 0.7848 L22: 1.0192 REMARK 3 L33: 0.5295 L12: -0.4590 REMARK 3 L13: 0.3494 L23: -0.2031 REMARK 3 S TENSOR REMARK 3 S11: 0.0276 S12: -0.0208 S13: 0.0318 REMARK 3 S21: -0.0466 S22: -0.0276 S23: -0.0331 REMARK 3 S31: 0.0178 S32: -0.0382 S33: 0.0000 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 285 A 498 REMARK 3 ORIGIN FOR THE GROUP (A): 9.2806 -4.9534 16.7222 REMARK 3 T TENSOR REMARK 3 T11: 0.0271 T22: 0.0084 REMARK 3 T33: 0.0344 T12: 0.0054 REMARK 3 T13: 0.0125 T23: 0.0159 REMARK 3 L TENSOR REMARK 3 L11: 0.8619 L22: 0.5018 REMARK 3 L33: 1.3083 L12: 0.1954 REMARK 3 L13: -0.2156 L23: -0.4624 REMARK 3 S TENSOR REMARK 3 S11: -0.0356 S12: -0.0501 S13: -0.0640 REMARK 3 S21: -0.0049 S22: -0.0120 S23: -0.0383 REMARK 3 S31: 0.1238 S32: 0.0202 S33: 0.0475 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. REMARK 4 REMARK 4 5FRI COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 17-DEC-15. REMARK 100 THE DEPOSITION ID IS D_1290065854. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID29 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.98 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 19007 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.800 REMARK 200 RESOLUTION RANGE LOW (A) : 58.120 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.2 REMARK 200 DATA REDUNDANCY : 5.000 REMARK 200 R MERGE (I) : 0.04000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 11.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.90 REMARK 200 COMPLETENESS FOR SHELL (%) : 70.7 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 40.99 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.08 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: SITTING DROP METHOD. DROPS PROTEIN REMARK 280 -PRECIPITANT 1-1, PROTEIN: 10MG/ML ALK5, PRECIPITANT: 20-30% REMARK 280 PEG8K, 100 MM PCTP BUFFER PH 8.5-9.2, 0.2 M NAAC, VAPOR REMARK 280 DIFFUSION, SITTING DROP REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 20.98000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 44.53500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 38.35000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 44.53500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 20.98000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 38.35000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 213 CE NZ REMARK 470 LYS A 223 NZ REMARK 470 ARG A 240 CD NE CZ NH1 NH2 REMARK 470 LYS A 391 CE NZ REMARK 470 ASN A 456 CG OD1 ND2 REMARK 470 LYS A 490 CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ILE A 201 -86.95 -114.13 REMARK 500 GLN A 324 49.01 -102.81 REMARK 500 ARG A 332 -1.93 77.86 REMARK 500 ASP A 333 43.43 -147.48 REMARK 500 ASP A 351 71.38 60.99 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 1499 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 1500 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZUQ A 1501 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5FQP RELATED DB: PDB REMARK 900 SELECTIVE ESTROGEN RECEPTOR DOWNREGULATOR ANTAGONISTS: REMARK 900 TETRAHYDROISOQUINOLINE PHENOLS 1. REMARK 900 RELATED ID: 5FQR RELATED DB: PDB REMARK 900 SELECTIVE ESTROGEN RECEPTOR DOWNREGULATOR ANTAGONISTS: REMARK 900 TETRAHYDROISOQUINOLINE PHENOLS 2. REMARK 900 RELATED ID: 5FQS RELATED DB: PDB REMARK 900 SELECTIVE ESTROGEN RECEPTOR DOWNREGULATOR ANTAGONISTS: REMARK 900 TETRAHYDROISOQUINOLINE PHENOLS 3. REMARK 900 RELATED ID: 5FQT RELATED DB: PDB REMARK 900 SELECTIVE ESTROGEN RECEPTOR DOWNREGULATOR ANTAGONISTS: REMARK 900 TETRAHYDROISOQUINOLINE PHENOLS 4. REMARK 900 RELATED ID: 5FQV RELATED DB: PDB REMARK 900 SELECTIVE ESTROGEN RECEPTOR DOWNREGULATOR ANTAGONISTS: REMARK 900 TETRAHYDROISOQUINOLINE PHENOLS 5. DBREF 5FRI A 200 498 UNP P36897 TGFR1_HUMAN 200 498 SEQADV 5FRI GLY A 198 UNP P36897 EXPRESSION TAG SEQADV 5FRI GLY A 199 UNP P36897 EXPRESSION TAG SEQRES 1 A 301 GLY GLY THR ILE ALA ARG THR ILE VAL LEU GLN GLU SER SEQRES 2 A 301 ILE GLY LYS GLY ARG PHE GLY GLU VAL TRP ARG GLY LYS SEQRES 3 A 301 TRP ARG GLY GLU GLU VAL ALA VAL LYS ILE PHE SER SER SEQRES 4 A 301 ARG GLU GLU ARG SER TRP PHE ARG GLU ALA GLU ILE TYR SEQRES 5 A 301 GLN THR VAL MET LEU ARG HIS GLU ASN ILE LEU GLY PHE SEQRES 6 A 301 ILE ALA ALA ASP ASN LYS ASP ASN GLY THR TRP THR GLN SEQRES 7 A 301 LEU TRP LEU VAL SER ASP TYR HIS GLU HIS GLY SER LEU SEQRES 8 A 301 PHE ASP TYR LEU ASN ARG TYR THR VAL THR VAL GLU GLY SEQRES 9 A 301 MET ILE LYS LEU ALA LEU SER THR ALA SER GLY LEU ALA SEQRES 10 A 301 HIS LEU HIS MET GLU ILE VAL GLY THR GLN GLY LYS PRO SEQRES 11 A 301 ALA ILE ALA HIS ARG ASP LEU LYS SER LYS ASN ILE LEU SEQRES 12 A 301 VAL LYS LYS ASN GLY THR CYS CYS ILE ALA ASP LEU GLY SEQRES 13 A 301 LEU ALA VAL ARG HIS ASP SER ALA THR ASP THR ILE ASP SEQRES 14 A 301 ILE ALA PRO ASN HIS ARG VAL GLY THR LYS ARG TYR MET SEQRES 15 A 301 ALA PRO GLU VAL LEU ASP ASP SER ILE ASN MET LYS HIS SEQRES 16 A 301 PHE GLU SER PHE LYS ARG ALA ASP ILE TYR ALA MET GLY SEQRES 17 A 301 LEU VAL PHE TRP GLU ILE ALA ARG ARG CYS SER ILE GLY SEQRES 18 A 301 GLY ILE HIS GLU ASP TYR GLN LEU PRO TYR TYR ASP LEU SEQRES 19 A 301 VAL PRO SER ASP PRO SER VAL GLU GLU MET ARG LYS VAL SEQRES 20 A 301 VAL CYS GLU GLN LYS LEU ARG PRO ASN ILE PRO ASN ARG SEQRES 21 A 301 TRP GLN SER CYS GLU ALA LEU ARG VAL MET ALA LYS ILE SEQRES 22 A 301 MET ARG GLU CYS TRP TYR ALA ASN GLY ALA ALA ARG LEU SEQRES 23 A 301 THR ALA LEU ARG ILE LYS LYS THR LEU SER GLN LEU SER SEQRES 24 A 301 GLN GLN HET EDO A1499 4 HET EDO A1500 4 HET ZUQ A1501 23 HETNAM EDO 1,2-ETHANEDIOL HETNAM ZUQ N-[4-[(6-CHLORO-[1,3]DIOXOLO[4,5-B]PYRIDIN-7-YL)AMINO]- HETNAM 2 ZUQ 2-PYRIDYL]CYCLOPROPANECARBOXAMIDE HETSYN EDO ETHYLENE GLYCOL FORMUL 2 EDO 2(C2 H6 O2) FORMUL 4 ZUQ C15 H13 CL N4 O3 FORMUL 5 HOH *241(H2 O) HELIX 1 1 ILE A 201 ARG A 203 5 3 HELIX 2 2 GLU A 238 GLN A 250 1 13 HELIX 3 3 SER A 287 TYR A 295 1 9 HELIX 4 4 THR A 298 MET A 318 1 21 HELIX 5 5 LYS A 335 LYS A 337 5 3 HELIX 6 6 THR A 375 MET A 379 5 5 HELIX 7 7 ALA A 380 ASP A 385 1 6 HELIX 8 8 HIS A 392 ARG A 414 1 23 HELIX 9 9 SER A 437 CYS A 446 1 10 HELIX 10 10 PRO A 455 SER A 460 5 6 HELIX 11 11 CYS A 461 TRP A 475 1 15 HELIX 12 12 ASN A 478 ARG A 482 5 5 HELIX 13 13 THR A 484 GLN A 498 1 15 SHEET 1 AA 5 ILE A 205 LYS A 213 0 SHEET 2 AA 5 GLU A 218 TRP A 224 -1 O VAL A 219 N ILE A 211 SHEET 3 AA 5 GLU A 227 SER A 235 -1 O GLU A 227 N TRP A 224 SHEET 4 AA 5 THR A 274 ASP A 281 -1 O LEU A 276 N PHE A 234 SHEET 5 AA 5 PHE A 262 ASP A 269 -1 N ILE A 263 O VAL A 279 SHEET 1 AB 3 ILE A 329 ALA A 330 0 SHEET 2 AB 3 VAL A 356 ASP A 359 -1 O VAL A 356 N ALA A 330 SHEET 3 AB 3 THR A 364 ILE A 365 -1 O THR A 364 N ASP A 359 SHEET 1 AC 2 ILE A 339 VAL A 341 0 SHEET 2 AC 2 CYS A 347 ILE A 349 -1 O CYS A 348 N LEU A 340 SITE 1 AC1 5 ASP A 269 GLY A 271 THR A 272 TRP A 273 SITE 2 AC1 5 HOH A2074 SITE 1 AC2 5 HIS A 256 GLU A 257 THR A 272 GLU A 447 SITE 2 AC2 5 HOH A2055 SITE 1 AC3 16 ILE A 211 VAL A 219 ALA A 230 LYS A 232 SITE 2 AC3 16 SER A 280 ASP A 281 TYR A 282 HIS A 283 SITE 3 AC3 16 GLU A 284 GLY A 286 THR A 323 LEU A 340 SITE 4 AC3 16 ASP A 351 HOH A2042 HOH A2094 HOH A2241 CRYST1 41.960 76.700 89.070 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.023832 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013038 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011227 0.00000